Agilon Health to Present Growth Plans at Conference
RBC Capital Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $3
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $4
Agilon Health Price Target Lowered to $4 From $8 at Wells Fargo
Express News | Agilon Health Inc : Benchmark Cuts Target Price to $3
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Citi Maintains Agilon Health(AGL.US) With Sell Rating, Cuts Target Price to $1.75
Agilon Health Shares Are Trading Lower After Stifel Cut Its Price Target on the Stock From $7 to $2.
Agilon Health Reports ACO REACH Model Results for 2023 Performance Year
Express News | Agilon Health Reports Aco Reach Model Results for 2023 Performance Year
Agilon Health Is Maintained at Underweight by Barclays
Agilon Health Analyst Ratings
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $2
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
BTIG Maintains Agilon Health(AGL.US) With Hold Rating
Agilon Health's Q3 2024 Financial Struggles and Cost Management Challenges Justify Hold Rating
Agilon Health Price Target Lowered to $2 From $5 at Barclays
Agilon Health Downgraded to Market Perform From Outperform at JMP Securities
JMP Securities Downgrades Agilon Health(AGL.US) to Hold Rating
No Data
No Data